News

Sinovant Sciences and Renexxion announced the initiation of a collaboration to pursue the development of naronapride, an investigational gastrointestinal prokinetic, in Greater China.…
Read More...

leon-nanodrugs GmbH announce that its proprietary MicroJet Reactor (MJR) nano-technology has been selected by Takeda Pharmaceutical Company Ltd. (Takeda) for a feasibility assessment…
Read More...

Edge Pharmacy Services, LLC announced that it has acquired Apolab ULC of Mississauga, Ontario. Edge is a rapidly growing US based 503B Outsourcing facility with business elements…
Read More...

Nohla Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Nohla’s lead product candidate, dilanubicel (NLA101), Orphan Drug Designation for reduction of…
Read More...

Cryoport announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport's full suite of temperature-controlled solutions into its global network. This integrated…
Read More...

GSK announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor…
Read More...

The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared smallpox,…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) seeking approval…
Read More...

Sirona Biochem Corp. announced that partner, Jiangsu Wanbang Biopharmaceuticals, has confirmed the Investigational New Drug (IND) submission to China’s Food and Drug Administration…
Read More...

Genmab A/S announced that it has entered into a research collaboration and exclusive license agreement with privately owned Immatics Biotechnologies GmbH (Immatics), to discover and…
Read More...

Pfenex Inc. announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate…
Read More...

UL announced that together with Applied DNA Sciences Inc. they have joined forces to form a strategic partnership that will lay the foundation for a significant new development in…
Read More...

Otsuka Pharmaceutical and Visterra announce that they have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately USD 430 million in…
Read More...

BioNTech AG and Genevant Sciences announced that they have entered into a collaboration to develop five mRNA therapeutic programs for rare diseases with high unmet medical need. The…
Read More...

CURE Pharmaceutical announced that it has signed a term sheet with Therapix Biosciences to acquire the non-pain assets of Therapix, subject to the completion of the related conditions.…
Read More...

AbbVie announced an update on a Phase 3 study (DBL3001) of ibrutinib (IMBRUVICA) in untreated (treatment-naïve) diffuse large B-cell lymphoma (DLBCL), an aggressive form of non-Hodgkin…
Read More...

Amphastar Pharmaceuticals announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals. To date, ANP has provided Active Pharmaceutical Ingredients and…
Read More...

Filament BioSolutions, a development-stage company focused on delivering innovative therapeutics for nutritional deficiencies, announced continued progress in the development of its…
Read More...

Catalent Pharma Solutions and Berkeley Lights announced Catalent Biologics will adopt BLI’s Beacon optofluidic platform to accelerate its cell line development workflow. The Beacon…
Read More...

Selexis SA announced that under the terms of an earlier commercial license agreement, Symphogen A/S has opened two investigational new drug applications (INDs) for clinical programs…
Read More...